Medical Disclaimer, 503A Compounding & Patient Safety
Mandatory clinical disclosure regarding compounded prescription medications and telehealth services.
1. General Clinical Disclaimer
The information presented across this website is provided solely for educational and informational purposes and does not constitute formal medical advice, diagnosis, or in-person treatment. Therapeutic determinations regarding any medical program are made exclusively pursuant to the independent clinical judgment of a licensed healthcare provider following individualized evaluation.
2. 503A Compounded Prescription Formulations
Compounded medications (such as compounded Semaglutide, compounded Tirzepatide, bioactive peptides, and bioidentical hormones) are custom-prepared by licensed compounding pharmacies in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act) pursuant to patient-specific prescriptions. Compounded medications are not pre-approved by the FDA in the same manner as mass-manufactured commercial drugs, but are prepared using USP/NF grade Active Pharmaceutical Ingredients (APIs) subject to strict analytical potency and sterility testing.
3. 49-State Provider Network (Excluding California) & Temperature-Controlled Shipping
Telehealth evaluations are conducted by licensed, credentialed practitioners authorized across 49 U.S. jurisdictions, excluding California. All temperature-sensitive medications are shipped via cold-chain insulated medical packaging directly to your doorstep.
4. Emergency Medical Protocol (911 Notice)
NECTALIS LLC does not provide acute emergency services. If you believe you are experiencing an acute medical emergency, severe adverse reaction, or critical symptom, dial 911 immediately or seek emergency medical care at the nearest hospital.
5. Biological Variability & Outcome Disclosures
Physiological responses and clinical outcomes vary by individual based on baseline metabolic markers, protocol adherence, dietary nutrition, and genetic profile. NECTALIS LLC makes no warranties of identical outcomes. For clinical coordination inquiries, contact: hello@nectalis.net.